RichardDavisShellMD

Associate Clinical Professor of Pediatrics, Ohio State University

Dr. Shell is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
700 Childrens Dr
Columbus, OH 43205
Phone+1 614-722-4766

Fax+1 614-722-4755

Nationwide Children's Hospital/Ohio State UniversityFellowship, Pediatric Pulmonology, 1996 - 1999
Nationwide Children's Hospital/Ohio State UniversityResidency, Pediatrics, 1993 - 1996
The University of Toledo College of MedicineClass of 1993

PubMed

137 citations
Five-Year Extension Results of the Phase 1 START Trial of Onasemnogene Abeparvovec in Spinal Muscular Atrophy.
Jerry R. Mendell, Samiah Al-Zaidy, Kelly J. Lehman, Markus McColly, Linda Lowes
JAMA Neurology. 2021-07-01
1321 citations
Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
Jerry R. Mendell, Samiah Al-Zaidy, Richard Shell, W. Dave Arnold, Louise R. Rodino-Klapac
The New England Journal of Medicine. 2017-11-01
108 citations
AVXS-101 (Onasemnogene Abeparvovec) for SMA1: Comparative Study with a Prospective Natural History Cohort.
Samiah Al-Zaidy, Stephen J. Kolb, Linda Lowes, Lindsay N. Alfano, Richard Shell
Journal of Neuromuscular Diseases. 2019-01-01

Journal Articles

Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children with Duchenne Muscular Dystrophy
Jerry R Mendell, Zarife Sahenk, Samiah Al-Zaidy, Richard Shell, JAMA Neurology

Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children with Duchenne Muscular DystrophyJune 2020

AveXis to Present AVXS-101 Data at the Annual Meeting of the American Academy of NeurologyApril 19th, 2018